Albany, NY, March 01, 2013 --(PR.com
)-- The study comprises of a strategic analysis of the global market for renal denervation devices, and growth forecast for the period from 2012 – 2021. The scope of the report includes competitive analysis of various market segments based on the product, technology and in-depth scrutiny for different regional markets such as North America, Europe, Asia-Pacific and the rest of the world. The Porter’s Five Forces analysis included in the report provides an insight into market dynamics and industry competition. The report also offers a PESTLE analysis on the market segments with regards to the future, segregated in different chapters. The report details across from 2012 to 2021 which includes the information of all projected activities in every phase of the report. The market forecast has been separated in three groups of years (2012-2015, 2015-2018 and 2018-2021) to include a separate analysis of each group. The unique analysis in this way covers all current and predicted future activities though this period and highlights key milestones in the progress of this market in the coming years.
To Buy The Copy Of This Report Visit: http://www.marketresearchreports.biz/analysis-details/renal-denervation-devices-market-global-industry-size-share-trends-analysis-and-forecasts-2012-2018.
This report provides complete insights on the RDN devices market and also analyzes various factors responsible for market growth. These factors determine various existing trends and their impact on market growth. In all, the report includes a holistic analysis of the global renal denervation devices market, and provides an estimate of growth for the period 2012 – 2021, keeping in mind the various factors affecting the market.
This report also analyzes current trends for hypertension treatment methods and advantages of renal denervation systems over other methods which act as a catalyst for the growth in the market. The report provides analysis of the most popular RDN device platforms such as Medtronic’s Symplicity, Covidien’s OneShot, Boston Scientific’s (Vessix Vascular) V2 system, and other emerging devices which will enable stakeholders to map their strategies.
The report also analyzes growth strategies implemented by existing players which will guide emerging players to develop their own strategies and helps existing players to structure their planning process. The report also includes entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in tactical decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help manufacturers, suppliers and distributors in the renal denervation field to plan and implement their roadmap in different market areas such as emerging geographies and new technologies.
To Read The Complete Report with TOC Kindly Visit: http://www.marketresearchreports.biz/analysis/138724.
1.2 Renal Denervation Devices: Market Segmentation
The study segments the market by technologies used for denervation such as Radiofrequency, Ultrasound, Micro-infusion of drugs (Chemical) and radiation. The report also segments the market according to the brand of products available in the market, particularly, Symplicity, EnligHTN, OneShot, V2 and others. Finally the report has given an in-depth analysis of the epidemiology, growth drivers and restraints by geography in the final section.
For More Information Contact:
90 State Street, Suite 700
Albany, NY 12207